Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of sitagliptin + metformin 50/1000 mg vs Janumet 50/1000 mg under fed conditions in healthy Thai volunteers
TCTR20220510006Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sitagliptin + metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Bio-innova. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
sitagliptin + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20220510006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220510006.